All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LTD Last Reported: 3/31/2024 Stock Symbol:

Business Address

SUITE 901, TESBURY CENTRE,
28 QUEEN'S ROAD EAST
WANCHAI , HK 00000

Mailing Address

SUITE 901, TESBURY CENTRE,
28 QUEEN'S ROAD EAST
WANCHAI , HK 00000
Phone Number: 011 852 2919-8916 / State Incorporated: / Fiscal Year End 3 /31

Balance Sheet

Date 3/31/2024 6/30/2023 3/31/2023 3/31/2022 3/31/2021 9/30/2020 3/31/2020 9/30/2019 3/31/2019 12/31/2018 6/30/2018 3/31/2018 12/31/2017 6/30/2017
Cash and Cash Equivalents -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accounts Receivable Net Current $790,626.00 $1,272,232.00 $353,703.00 $194,138.00 $264,749.00 $57,802.00 $329,891.00 -- $363,491.00 -- -- -- -- --
Inventory $29,659.00 $101,069.00 $131,474.00 $1,238,316.00 $1,487,683.00 $108,046.00 $224,879.00 -- $246,881.00 -- -- -- -- --
Prepaid Expenses and Other Current Assets $142,859.00 $319,991.00 $280,424.00 $224,392.00 $301,370.00 $280,419.00 $141,017.00 -- $187,770.00 -- -- -- -- --
Total Current Assets $2,026,173.00 $1,929,142.00 $1,200,263.00 $2,082,902.00 $2,436,594.00 $1,477,596.00 $1,529,238.00 -- $1,866,375.00 -- -- -- -- --
Property Plant and Equipement $2,395.00 $3,857.00 $4,772.00 $10,659.00 $15,353.00 $45,625.00 $9,839.00 -- $9,343.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $3,168,233.00 $3,165,691.00 $2,280,444.00 $2,852,875.00 $3,457,596.00 $2,907,509.00 $2,279,457.00 -- $1,875,718.00 $100.00 $100.00 -- $100.00 --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities $732,552.00 -- $448,093.00 $209,019.00 -- -- -- -- -- $21,859.00 $7,300.00 -- $14,041.00 --
Total Current Liabilities $3,387,027.00 $3,019,217.00 $2,610,389.00 $1,911,475.00 $1,957,103.00 $1,611,088.00 $799,647.00 -- $423,647.00 $76,797.00 $44,618.00 -- $26,641.00 --
Long Term Debt $1,887,458.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $179,191.00 $172,093.00 $96,918.00 $176,480.00 $162,145.00 $127,188.00 $113,440.00 -- $127,669.00 -- -- -- -- --
Accumulated Deficit $-3,214,881.00 $-2,766,339.00 $-3,164,249.00 $-1,367,834.00 $-242,269.00 $-411,384.00 $-214,247.00 -- $-126,948.00 $-79,409.00 $-47,230.00 -- $-29,253.00 --
Total Stockholders' Equity $-204,549.00 $126,515.00 $-346,570.00 $941,400.00 $1,500,493.00 $1,296,421.00 $1,479,810.00 -- $1,452,071.00 $-76,697.00 $-44,518.00 $1,163,187.00 $-26,541.00 --
Controlling Interest in Subsidiaries $-14,245.00 $19,959.00 $16,625.00 -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $3,168,233.00 $3,165,691.00 $2,280,444.00 $2,852,875.00 $3,457,596.00 $2,907,509.00 $2,279,457.00 -- $1,875,718.00 $100.00 $100.00 -- $100.00 --

Statement of Operations

Date 3/31/2024 6/30/2023 3/31/2023 3/31/2022 3/31/2021 9/30/2020 3/31/2020 9/30/2019 3/31/2019 12/31/2018 6/30/2018 3/31/2018 12/31/2017 6/30/2017
Total Revenues $2,278,246.00 $1,098,476.00 $1,662,600.00 $2,328,526.00 $1,624,086.00 $664,093.00 $1,219,650.00 $756,063.00 $1,217,588.00 -- -- -- -- --
Cost of Revenues $206,374.00 $68,609.00 $144,683.00 $846,968.00 $270,628.00 $201,356.00 $257,034.00 $170,280.00 $320,836.00 -- -- -- -- --
Gross Profit -- $1,029,867.00 $1,517,917.00 $1,481,558.00 $1,353,458.00 $462,737.00 $962,616.00 $585,783.00 $896,752.00 -- -- -- -- --
Research and Development $493,839.00 $358,724.00 $357,823.00 $680,313.00 $211,037.00 $114,109.00 $182,309.00 $48,109.00 $42,704.00 -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $2,011,689.00 $631,830.00 $2,771,413.00 -- -- $662,351.00 -- $435,283.00 -- $50,156.00 $17,977.00 -- -- $2,000.00
Loss from Operations $266,557.00 $398,037.00 $-1,253,496.00 $-1,129,186.00 $-14,595.00 -- $-85,509.00 -- $312,136.00 $-50,156.00 -- -- -- --
Loss Before Income Taxes $271,275.00 -- -- -- -- -- -- -- -- -- $-6,116.00 -- -- $-2,000.00
Earnings Per Share Basic $-0.02 $2.25 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 17,692,853 17,679,618 17,666,043 -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.02 $2.21 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 17,992,853 17,979,618 17,666,043 -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 50,000,000 50,000,000 50,000,000 50,000,000 500,000,000 50,000,000 500,000,000 -- 500,000,000 100,000,000 100,000,000 -- 100,000,000 --
Common Stock Shares Outstanding 17,709,718 17,679,618 17,679,618 17,547,118 171,450,000 17,145,000 171,450,000 -- 161,500,000 8,500,000 8,500,000 -- 8,500,000 --
Common Stock Value $17,710.00 $17,680.00 $17,680.00 $17,547.00 $17,145.00 $17,145.00 $17,145.00 -- $16,150.00 $850.00 $850.00 -- $850.00 --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 -- $0.00 --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- 20,000,000 20,000,000 -- 20,000,000 --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- $0.00 $0.00 -- $0.00 --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2025 PursePoor.com